A drug used
with lenalidomide and dexamethasone to treat multiple
myeloma. It is used in patients whose cancer was treated
with one to three anticancer therapies.
Elotuzumab binds to a protein
called CS1, which is found on myeloma cells and some types
of immune cells. Elotuzumab may
block CS1 and help the immune system kill cancer cells. It
is a type of monoclonal antibody. Also called Empliciti and HuLuc63.